How many patents does
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii have?
patents
282
families
33
granted
65
applications
217
EP
40
WO
37
US
34
CN
13
KR
11
JP
11
RoW
136
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii
Top ten assignees appearing on patents
2009 - 2018
| roche | 4 |
| diagnoswiss | 4 |
| polyquant | 4 |
| bosch tubert, fatima | 1 |
| plant bioscience | 1 |
| biotesys | 1 |
| nestec | 1 |
2009
2018
| polyquant | 2 |
| diagnoswiss | 2 |
| biotesys | 1 |
| nestec | 1 |
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| chemical entities | 36 | 2013 |
| imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives | 30 | 2009 |
| process for the identification of compounds for treating cancer | 29 | 2009 |
| imidazopyrazines for use as kinase inhibitors | 27 | 2009 |
| macrocyclic compounds as protein kinase inhibitors | 22 | 2011 |
| tricyclic compounds for use as kinase inhibitors | 16 | 2009 |
| imidazolothiadiazoles for use as protein kinase inhibitors | 15 | 2007 |
| anti-ephrin-b2 antibody and use thereof | 13 | 2010 |
| methods for the diagnosis or prognosis of colorectal cancer | 12 | 2009 |
| manipulation of stem cell function by p53 isoforms | 8 | 2010 |